Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Discontinuation of Oral HT & Sexual Activity

Menopause; ePub 2017 Nov 6; Gass, et al

In the postintervention phase of the Women’s Health Initiative Hormone Therapy trials, estrogen therapy (ET) participants formerly assigned to ET were significantly more likely to report sexual activity than those formerly assigned to placebo. Also, women who discontinued estrogen-progestin therapy (EPT) were significantly more likely to report negative vaginal and sex-related effects. Surveys were sent postintervention to those who were still taking study pills and agreed to continue in the study when the trials were stopped. 13,902 women (mean age at survey ~70 years for EPT trial, women with intact uterus and 71.7 years for ET trial, women with history of hysterectomy) were included. Researchers found:

  • Prevalence of sexual activity postintervention was not significantly different between former EPT and placebo users.
  • Sexual activity of former ET users was 5.6% higher vs placebo users.
  • Most sexually active women overall maintained orgasmic capacity and sexual satisfaction.
  • Former EPT users were 10% to 12% more likely than former placebo users to report decreased desire, arousal, intercourse, climax, and satisfaction with sexual activity.
  • Former ET users were more likely than placebo users to report rare to no desire or arousal postintervention.

Citation:

Gass M, Larson J, Cochrane B, et al. Sexual activity and vaginal symptoms in the postintervention phase of the Women’s Health Initiative Hormone Therapy trials. [Published online ahead of print November 6, 2017]. Menopause. doi:10.1097/GME.0000000000000994.

This Week's Must Reads

Low Dose Aspirin and Spontaneous Preterm Birth, Am J Obstet Gynecol; ePub 2018 Jun 15; Andrikopoulou, et al

New Persistent Opioid Use After Hysterectomy, Am J Obstet Gynecol; ePub 2018 Jun 18; Swenson, et al

Salpingectomy at Time of Cesarean Delivery, Contraception; ePub 2018 Jun 20; Lehn, et al

Cardiac Autonomic Function in Midlife Women, Menopause; ePub 2018 Jun 18; Fu, et al

ACOG Recommendations for Maternal Immunization, Obstet Gynecol; ePub 2018 Jun; Ault, Riley, et al

Must Reads in Menopause

Cardiac Autonomic Function in Midlife Women, Menopause; ePub 2018 Jun 18; Fu, et al

Vasomotor Symptoms in Older Women, Menopause; ePub 2018 May 7; David, et al

Estrogen-alone Therapy & Invasive Breast Cancer, Menopause; ePub 2018 May 7; Shufelt, et al

Vascular Dysfunction During Menopausal Transition, Menopause; ePub 2018 Apr 9; Hildreth, et al

Menopausal HT & Hyperkyphosis Prevention , Menopause; ePub 2018 Feb 16; Woods, et al